Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access

Ian Hirsch; Daniel A. Goldstein; Ian F. Tannock; Marcus O. Butler; Duncan C. Gilbert

doi:10.1038/s41591-022-02029-1

Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access

Ian Hirsch, Daniel A. Goldstein, Ian F. Tannock, Marcus O. Butler, Duncan C. Gilbert^*

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2236-2237
Number of pages	2
Journal	Nature Medicine
Volume	28
Issue number	11
DOIs	https://doi.org/10.1038/s41591-022-02029-1
State	Published - Nov 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41591-022-02029-1

Cite this

@article{58ed827b68d2449fa35bbe6e9dbe9f32,

title = "Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access",

author = "Ian Hirsch and Goldstein, {Daniel A.} and Tannock, {Ian F.} and Butler, {Marcus O.} and Gilbert, {Duncan C.}",

note = "Funding Information: The analysis and conclusions set forth are those of the authors and do not indicate concurrence by other members of the research staff of the Federal Reserve System or of the Board of Governors. Research supported in part by National Science Foundation grant SES-1846832. ",

year = "2022",

month = nov,

doi = "10.1038/s41591-022-02029-1",

language = "אנגלית",

volume = "28",

pages = "2236--2237",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access

AU - Hirsch, Ian

AU - Goldstein, Daniel A.

AU - Tannock, Ian F.

AU - Butler, Marcus O.

AU - Gilbert, Duncan C.

N1 - Funding Information: The analysis and conclusions set forth are those of the authors and do not indicate concurrence by other members of the research staff of the Federal Reserve System or of the Board of Governors. Research supported in part by National Science Foundation grant SES-1846832.

PY - 2022/11

Y1 - 2022/11

UR - http://www.scopus.com/inward/record.url?scp=85139493268&partnerID=8YFLogxK

U2 - 10.1038/s41591-022-02029-1

DO - 10.1038/s41591-022-02029-1

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 36202999

AN - SCOPUS:85139493268

SN - 1078-8956

VL - 28

SP - 2236

EP - 2237

JO - Nature Medicine

JF - Nature Medicine

IS - 11

ER -

Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access

UN SDGs

Access to Document

Other files and links

Cite this